(MENAFN- EIN Presswire) hydrocephalus industry 2030
PORTLAND, OREGON, UNITED STATES, May 26, 2023 /einpresswire.com / -- According to the report, the global hydrocephalus industry generated $6.90 billion in 2020, and is expected to reach $10.17 billion by 2030, witnessing a CAGR of 4.0% from 2021 to 2030. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.
Key Takeaways:
Market Growth: The hydrocephalus market has been witnessing significant growth over the years. The increasing prevalence of hydrocephalus, coupled with advancements in healthcare technology, is driving market expansion.
Prevalence: Hydrocephalus is a relatively common neurological condition characterized by an abnormal accumulation of cerebrospinal fluid (CSF) within the brain. It can occur at any age, from infants to the elderly. The exact prevalence rates may vary by region, but it is estimated to affect approximately 1 to 1.5 per 1,000 live births.
Treatment Options: The primary treatment for hydrocephalus is surgical intervention. The most common surgical procedure is the placement of a shunt system, which helps divert the excess CSF from the brain to another part of the body, such as the abdomen, where it can be absorbed. Endoscopic third ventriculostomy (ETV) is another surgical option that involves creating an opening in the floor of the third ventricle to allow CSF to flow properly.
Shunt Systems Dominance: Shunt systems have been the gold standard for hydrocephalus treatment for many years. They consist of a catheter system with a valve that regulates CSF flow. However, shunt-related complications, such as infection, blockage, and malfunction, remain significant challenges in the management of hydrocephalus.
Technological Advancements: Ongoing research and development efforts are focused on improving shunt technology, reducing complications, and developing alternative treatment modalities. Some of the advancements include programmable valves that allow for personalized adjustments, anti-microbial materials to prevent infections, and new valve designs to enhance reliability.
Request Sample Copy of the Report:
Market Drivers:
Increasing Prevalence: Hydrocephalus is a relatively common neurological disorder that affects individuals of all ages. The rising prevalence of hydrocephalus, both in pediatric and adult populations, is a significant driver for market growth. Factors such as improved diagnosis, increased awareness, and advancements in medical imaging techniques have led to better identification and management of hydrocephalus cases.
Technological Advancements: Advances in medical technology have revolutionized the diagnosis and treatment of hydrocephalus. Innovations in imaging modalities, such as magnetic resonance imaging (MRI), have enabled better visualization of the brain structures and abnormalities associated with hydrocephalus. Additionally, the development of improved shunt systems, including programmable valves, antimicrobial materials, and enhanced catheter designs, has positively impacted patient outcomes and reduced complications.
Market Segmentation:
Type of Hydrocephalus:
a. Congenital Hydrocephalus: Present at birth, often due to developmental abnormalities or genetic factors.
b. Acquired Hydrocephalus: Develops later in life due to conditions such as tumors, infections, or head trauma.
Age Group:
a. Pediatric Hydrocephalus: Affects infants and children.
b. Adult Hydrocephalus: Occurs in adults, usually as a result of conditions like subarachnoid hemorrhage or normal-pressure hydrocephalus.
Treatment Type:
a. Shunt Systems: Includes ventriculoperitoneal (VP) shunts, ventriculoatrial (VA) shunts, and other variants.
b. Endoscopic Third Ventriculostomy (ETV): Minimally invasive surgical procedure that creates an opening in the third ventricle to facilitate CSF flow.
c. Alternative Therapies: Various emerging treatment modalities being explored, such as minimally invasive endoscopic procedures, choroid plexus cauterization, and aqueductal stenting.
End User:
a. Hospitals and Surgical Centers: Facilities providing surgical interventions and postoperative care.
b. Specialty Clinics and Rehabilitation Centers: Centers specializing in the management and long-term care of hydrocephalus patients.
c. Research and Academic Institutions: Institutions involved in research, clinical trials, and the development of new treatment options.
Geography:
a. Regional Segmentation: Market analysis based on geographical regions, such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
b. Country-specific Segmentation: Focusing on individual countries or regions within a larger geographic area.
Request for Customization –
Regional Growth Dynamics:
North America held the highest market share in 2020, accounting for more than two-fifths of the global hydrocephalus market, and is expected to continue its lead in terms of revenue by 2030. This is due to rise in prevalence of the neurological disorder, increase in the number of hydrocephalus patients, development of advanced healthcare medical devices, and advancements in technology for hydrocephalus in the region. However, Asia-Pacific is expected to manifest the fastest CAGR of 5.0% during the forecast period. This is due to rise in awareness regarding minimally invasive surgeries, surge in cases of stroke and CSF related disorders, and technological advancements.
Competitive Landscape:
Medtronic plc
Johnson & Johnson
B. Braun Melsungen AG
Sophysa S.A.
Integra LifeSciences Corporation
Spiegelberg GmbH & Co. KG
Möller Medical GmbH
Natus Medical Incorporated
Miethke GmbH & Co. KG
Delta Surgical Limited
Buy this Premium Research Report:
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of“Market Research Reports” and“Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Analytics LLP
+ 1-800-792-5285
email us here